Clinical trial
Clinical Trial of SAHA in Patients With Breast Cancer
NCT00416130 · National University Hospital, Singapore, Other · Unknown status
Key facts
| NCT number | NCT00416130 |
|---|---|
| Title | Clinical Trial of SAHA in Patients With Breast Cancer |
| Official title | Phase I/II Clinical Trial of Vorinostat in Patients With Recurrent and/or Metastatic Breast Cancer |
| Lead sponsor | National University Hospital, Singapore, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Vorinostat |
| Enrollment | 49 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2015 |
| First posted | Dec 27, 2006 |
| Last update posted | Dec 10, 2013 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: